
IRadimed Corporation
IRMD
Updated: 22/09/2026, 20:39:46
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
No summaries found.
- Share price
- $85.08
- Market cap
- $1.09B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Roger E. Susi
- Employees
- 166
- IPO date
- 16/07/2014
- Beta
- 0.899
- Last dividend
- $0.00
- Day range
- $81.98 – $85.57
- 52-week range
- $67.84 – $107.90
- 1-day performance
- 3.18%
- 1-year performance
- 25.41%
- Current drawdown (1Y)
- -21.15%
- CIK
- 0001325618
- CUSIP
- 46266A109
- ISIN
- US46266A1097
- Created
- 07/12/2025, 04:46:31
- Last update
- 22/09/2026, 20:39:46
Track IRadimed Corporation with an AI analyst
See which prediction-market events move IRMD, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 01/05/2026, 20:11:36
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research • STOCK • 01/05/2026, 12:45:39
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
GlobeNewsWire • STOCK • 01/05/2026, 10:30:00
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
GlobeNewsWire • STOCK • 10/04/2026, 17:14:00
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
GlobeNewsWire • STOCK • 16/03/2026, 15:00:00